Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action

AboTaleb HA, Alghamdi BS (2020) Neuroprotective effects of melatonin during demyelination and remyelination stages in a mouse model of multiple sclerosis. J Mol Neurosci 70:386–402. https://doi.org/10.1007/s12031-019-01425-6CrossRef

Acuña-Castroviejo D, Martín M, Macías M et al (2001) Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res 30:65–74. https://doi.org/10.1034/J.1600-079X.2001.300201.XCrossRefPubMed

Adamczyk-Sowa M, Sowa P, Adamczyk J et al (2016a) Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone. J Physiol Pharmacol 67:235–242PubMed

Adamczyk-Sowa M, Sowa P, Mucha S et al (2016) Changes in serum ceruloplasmin levels based on immunomodulatory treatments and melatonin supplementation in multiple sclerosis patients. Med Sci Monit. https://doi.org/10.12659/MSM.895702CrossRefPubMedPubMedCentral

Adamczyk-Sowa M, Galiniak S, Zyracka E et al (2017) Oxidative modification of blood serum proteins in multiple sclerosis after interferon beta and melatonin treatment. Oxid Med Cell Longev. https://doi.org/10.1155/2017/7905148CrossRefPubMedPubMedCentral

Agüera E, Caballero-Villarraso J, Feijóo M et al (2020) Clinical and neurochemical effects of transcranial magnetic stimulation (TMS) in multiple sclerosis: a study protocol for a randomized clinical trial. Front Neurol. https://doi.org/10.3389/fneur.2020.00750CrossRefPubMedPubMedCentral

Akpinar Z, Tokgöz S, Gökbel H et al (2008) The association of nocturnal serum melatonin levels with major depression in patients with acute multiple sclerosis. Psychiatry Res 161:253–257. https://doi.org/10.1016/j.psychres.2007.11.022CrossRefPubMed

Albazal A, Delshad AA, Roghani M (2021) Melatonin reverses cognitive deficits in streptozotocin-induced type 1 diabetes in the rat through attenuation of oxidative stress and inflammation. J Chem Neuroanat. https://doi.org/10.1016/j.jchemneu.2020.101902CrossRefPubMed

Alghamdi BS, AboTaleb HA (2020) Melatonin improves memory defects in a mouse model of multiple sclerosis by up-regulating cAMP-response element-binding protein and synapse-associated proteins in the prefrontal cortex. J Integr Neurosci 19:229–237. https://doi.org/10.31083/j.jin.2020.02.32CrossRefPubMed

Álvarez-Sánchez N, Cruz-Chamorro I, López-González A et al (2015) Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance. Brain Behav Immun 50:101–114. https://doi.org/10.1016/j.bbi.2015.06.021CrossRefPubMed

Álvarez-Sánchez N, Cruz-Chamorro I, Díaz-Sánchez M et al (2017) Melatonin reduces inflammatory response in peripheral T helper lymphocytes from relapsing-remitting multiple sclerosis patients. J Pineal Res. https://doi.org/10.1111/jpi.12442CrossRefPubMed

Anderson G, Reiter RJ (2020) Melatonin: roles in influenza, Covid-19, and other viral infections. Rev Med Virol. https://doi.org/10.1002/rmv.2109CrossRefPubMedPubMedCentral

Anderson G, Rodriguez M, Reiter RJ (2019) Multiple sclerosis: melatonin, orexin, and ceramide interact with platelet activation coagulation factors and gut-microbiome-derived butyrate in the circadian dysregulation of mitochondria in glia and immune cells. Int J Mol Sci 20(21):5500. https://doi.org/10.3390/ijms20215500CrossRef

Anderson G, Carbone A, Mazzoccoli G (2020) Aryl hydrocarbon receptor role in co-ordinating sars-cov-2 entry and symptomatology: linking cytotoxicity changes in covid-19 and cancers; modulation by racial discrimination stress. Biology (basel) 9:1–31. https://doi.org/10.3390/biology9090249CrossRef

Ascherio A (2013) Environmental factors in multiple sclerosis. Expert Rev Neurother 13(12 Suppl):3–9. https://doi.org/10.1586/14737175.2013.865866CrossRefPubMed

Ascherio A, Munger KL, Simon KC (2010) Vitamin D and multiple sclerosis. Lancet Neurol 9:599–612CrossRef

Avila M, Bansal A, Culberson J, Peiris ANN (2018) The role of sex hormones in multiple sclerosis. Eur Neurol 80:93–99. https://doi.org/10.1159/000494262CrossRefPubMed

Azoulay D, Vachapova V, Shihman B et al (2005) Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate. J Neuroimmunol 167:215–218. https://doi.org/10.1016/j.jneuroim.2005.07.001CrossRefPubMed

Azoulay D, Urshansky N, Karni A (2008) Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection. J Neuroimmunol 195:186–193. https://doi.org/10.1016/j.jneuroim.2008.01.010CrossRefPubMed

Bahamonde C, Conde C, Agüera E et al (2014) Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: relationship to oxidative stress. Eur J Pharmacol 730:26–30. https://doi.org/10.1016/j.ejphar.2014.02.020CrossRefPubMed

Basoli V, Santaniello S, Cruciani S et al (2017) Melatonin and vitamin D interfere with the adipogenic fate of adipose-derived stem cells. Int J Mol Sci 18:981. https://doi.org/10.3390/ijms18050981CrossRefPubMedCentral

Beriwal N, Namgyal T, Sangay P, Al Quraan AM (2019) Role of immune-pineal axis in neurodegenerative diseases, unraveling novel hybrid dark hormone therapies. Heliyon. https://doi.org/10.1016/j.heliyon.2019.e01190CrossRefPubMedPubMedCentral

Bove R, Gilmore W (2018) Hormones and MS: Risk factors, biomarkers, and therapeutic targets. Mult Scler. https://doi.org/10.1177/1352458517737396CrossRefPubMedPubMedCentral

Bradshaw MJ, Holick MF, Stankiewicz JM (2020) Vitamin D and multiple sclerosis. Curr Clin Neurol. https://doi.org/10.1007/978-3-030-24436-1_10CrossRef

Camara-Lemarroy CR, Metz L, Meddings JB et al (2018) The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Brain 141:1900–1916. https://doi.org/10.1093/brain/awy131CrossRefPubMedPubMedCentral

Campbell GR, Mahad DJ (2011) Mitochondria as crucial players in demyelinated axons: lessons from neuropathology and experimental demyelination. Autoimmune Dis. https://doi.org/10.4061/2011/262847CrossRefPubMedPubMedCentral

Campbell GR, Ziabreva I, Reeve AK et al (2011) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol. https://doi.org/10.1002/ana.22109CrossRefPubMedPubMedCentral

Cardinali DP (2019) Melatonin: clinical perspectives in neurodegeneration. Front Endocrinol (Lausanne). https://doi.org/10.3389/fendo.2019.00480CrossRef

Carrascal L, Nunez-Abades P, Ayala A, Cano M (2018) Role of melatonin in the inflammatory process and its therapeutic potential. Curr Pharm Des 24:1563–1588. https://doi.org/10.2174/1381612824666180426112832CrossRefPubMed

Carrillo-Vico A, Lardone PJ, Naji L et al (2005) Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. J Pineal Res 39:400–408. https://doi.org/10.1111/j.1600-079X.2005.00265.xCrossRefPubMed

Carvalho AN, Lim JL, Nijland PG et al (2014) Glutathione in multiple sclerosis: more than just an antioxidant? Mult Scler J 20:1425–1431. https://doi.org/10.1177/1352458514533400CrossRef

Castro LMR, Gallant M, Niles LP (2005) Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. J Neurochem 95:1227–1236. https://doi.org/10.1111/j.1471-4159.2005.03457.xCrossRefPubMed

Chang C, Huang H, Lee H et al (2012) Melatonin attenuates kainic acid-induced neurotoxicity in mouse hippocampus via inhibition of autophagy and α-synuclein aggregation. J Pineal Res 52:312–321. https://doi.org/10.1111/J.1600-079X.2011.00945.XCrossRefPubMed

Chang T, Niu C, Sun C et al (2020) Melatonin exerts immunoregulatory effects by balancing peripheral effector and regulatory T helper cells in myasthenia gravis. Aging (Albany NY) 12:21147–21160. https://doi.org/10.18632/aging.103785CrossRef

Chen J, Chia N, Kalari KR et al (2016) Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep. https://doi.org/10.1038/srep28484CrossRefPubMedPubMedCentral

Chen D, Zhang T, Lee TH (2020) Cellular mechanisms of melatonin: Insight from neurodegenerative diseases. Biomolecules 10:1–26. https://doi.org/10.3390/biom10081158CrossRef

Chisu V, Manca P, Lepore G et al (2006) Testosterone induces neuroprotection from oxidative stress. Effects on catalase activity and 3-nitro-L-tyrosine incorporation into α-tubulin in a mouse neuroblastoma cell line. Arch Ital Biol 144:63–73. https://doi.org/10.4449/aib.v144i2.882CrossRefPubMed

Chitimus DM, Popescu MR, Voiculescu SE et al (2020) Melatonin’s impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease. Biomolecules 10:1–28. https://doi.org/10.3390/biom10091211CrossRef

Chitnis T (2013) Role of puberty in multiple sclerosis risk and course. Clin Immunol 149:192–200. https://doi.org/10.1016/J.CLIM.2013.03.014CrossRefPubMed

Claustrat B, Leston J (2015) Melatonin: physiological effects in humans. Neurochirurgie 61:77–84. https://doi.org/10.1016/J.NEUCHI.2015.03.002CrossRefPubMed

Claustrat B, Brun J, Chazot G (2005) The basic physiology and pathophysiology of melatonin. Sleep Med Rev 9:11–24. https://doi.org/10.1016/j.smrv.2004.08.001CrossRefPubMed

Cobianchi S, Arbat-Plana A, Lopez-Alvarez VM, Navarro X (2016) Neuroprotective effects of exercise treatments after injury: the dual role of neurotrophic factors. Curr Neuropharmacol 15:495–518. https://doi.org/10.2174/1570159x14666160330105132CrossRef

Comai S, Gobbi G (2014) Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology. J Psychiatry Neurosci 39(1):6–21. https://doi.org/10.1503/jpn.130009CrossRefPubMedPubMedCentral

Comini-Frota ER, Rodrigues DH, Miranda EC et al (2012) Serum levels of brain-derived neurotrophic factor correlate with the number of T2 MRI lesions in multiple sclerosis. Brazilian J Med Biol Res 45:68–71. https://doi.org/10.1590/S0100-879X2011007500165CrossRef

Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221–1231. https://doi.org/10.1016/S0140-6736(02)08220-XCrossRefPubMed

Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502–1517. https://doi.org/10.1016/S0140-6736(08)61620-7CrossRefPubMed

Conde C, Escribano BM, Luque E et al (2019) Extra-virgin olive oil modifies the changes induced in non-nervous organs and tissues by experimental autoimmune encephalomyelitis models. Nutrients. https://doi.org/10.3390/nu11102448CrossRefPubMedPubMedCentral

Constantinescu CS, Hilliard B, Ventura E, Rostami A (1997) Luzindole, a melatonin receptor antagonist, suppresses experimental autoimmune encephalomyelitis. Pathobiology. https://doi.org/10.1159/000164122CrossRefPubMed

Crespo I, San-Miguel B, Sánchez DI et al (2016) Melatonin inhibits the sphingosine kinase 1/sphingosine-1-phosphate signaling pathway in rabbits with fulminant hepatitis of viral origin. J Pineal Res. https://doi.org/10.1111/jpi.12335CrossRefPubMed

Curtis R, Adryan KM, Stark JL et al (1995) Differential role of the low affinity neurotrophin receptor (p75) in retrograde axonal transport of the neurotrophins. Neuron 14:1201–1211. https://doi.org/10.1016/0896-6273(95)90267-8CrossRefPubMed

Cutolo M, Wilder RL (2000) Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases. Rheum Dis Clin North Am 26:825–839. https://doi.org/10.1016/S0889-857X(05)70171-XCrossRefPubMed

Das R, Balmik AA, Chinnathambi S (2020) Melatonin reduces GSK3β-mediated Tau phosphorylation, enhances Nrf2 nuclear translocation and anti-inflammation. ASN Neuro. https://doi.org/10.1177/1759091420981204CrossRefPubMedPubMedCentral

De Nicola AF, Garay LI, Meyer M et al (2018) Neurosteroidogenesis and progesterone anti-inflammatory/neuroprotective effects. J Neuroendocrinol 30:e12502. https://doi.org/10.1111/jne.12502CrossRef

Di Monte D, Chan P, Sandy M (1992) Glutathione in Parkinson’s disease: a link between oxidative stress and mitochondrial damage? Ann Neurol 32(Suppl):S111–S115. https://doi.org/10.1002/ANA.410320719CrossRefPubMed

Di Stadio A, Romani L, Bernitsas E (2020) Could sars-Cov2 affect MS progression? Mult Scler Relat Disord. https://doi.org/10.1016/j.msard.2020.102540CrossRefPubMedPubMedCentral

Diez V, Traikov S, Schmeisser K et al (2021) Glycolate combats massive oxidative stress by restoring redox potential in caenorhabditis elegans. Commun Biol 4:1–13. https://doi.org/10.1038/s42003-021-01669-2CrossRef

Ding Z, Wu X, Wang Y et al (2020) Melatonin prevents LPS-induced epithelial-mesenchymal transition in human alveolar epithelial cells via the GSK-3β/Nrf2 pathway. Biomed Pharmacother. https://doi.org/10.1016/j.biopha.2020.110827CrossRefPubMedPubMedCentral

Dizdaroglu M (2005) Base-excision repair of oxidative DNA damage by DNA glycosylases. Mutat Res 591:45–59. https://doi.org/10.1016/J.MRFMMM.2005.01.033CrossRefPubMed

Duan J, Kang J, Qin W et al (2018) Exposure to formaldehyde and diisononyl phthalate exacerbate neuroinflammation through NF-κB activation in a mouse asthma model. Ecotoxicol Environ Saf 163:356–364. https://doi.org/10.1016/j.ecoenv.2018.07.089CrossRefPubMed

Dupuis ML, Pagano MT, Pierdominici M, Ortona E (2021) The role of vitamin D in autoimmune diseases: could sex make the difference? Biol Sex Differ. https://doi.org/10.1186/s13293-021-00358-3CrossRefPubMedPubMedCentral

El-Salem K, Khalil H, Al-Sharman A et al (2021) Serum vitamin d inversely correlates with depression scores in people with multiple sclerosis. Mult Scler Relat Disord. https://doi.org/10.1016/j.msard.2020.102732CrossRefPubMed

Escribano BM, Colin-Gonzalez A, Santamaria A, Tunez I (2014) The role of melatonin in multiple sclerosis, Huntington’s disease and cerebral ischemia. CNS Neurol Disord - Drug Targets 13:1096–1119. https://doi.org/10.2174/1871527313666140806160400CrossRefPubMed

Escribano BM, Medina-Fernández FJ, Aguilar-Luque M et al (2017) Lipopolysaccharide binding protein and oxidative stress in a multiple sclerosis model. Neurotherapeutics. https://doi.org/10.1007/s13311-016-0480-0CrossRefPubMed

Escribano BM, Muñoz-Jurado A, Caballero-Villarraso J et al (2022) Protective effects of melatonin on changes occurring in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Mult Scler Relat Disord 58:103520. https://doi.org/10.1016/J.MSARD.2022.103520CrossRefPubMed

Esposito E, Cuzzocrea S (2010) Antiinflammatory activity of melatonin in central nervous system. Curr Neuropharmacol 8:228–242. https://doi.org/10.2174/157015910792246155CrossRefPubMedPubMedCentral

Estrada C, López D, Conesa A et al (2015) Cognitive impairment after sleep deprivation rescued by transcranial magnetic stimulation application in octodon degus. Neurotox Res 28:361–371. https://doi.org/10.1007/s12640-015-9544-xCrossRefPubMed

Faissner S, Plemel JR, Gold R, Yong VW (2019) Progressive multiple sclerosis: from pathophysiology to therapeutic strategies. Nat Rev Drug Discov 18:905–922. https://doi.org/10.1038/s41573-019-0035-2CrossRefPubMed

Farez MF, Mascanfroni ID, Méndez-Huergo SP et al (2015) Melatonin contributes to the seasonality of multiple sclerosis relapses. Cell 162:1338–1352. https://doi.org/10.1016/j.cell.2015.08.025CrossRefPubMedPubMedCentral

Farez MF, Calandri IL, Correale J, Quintana FJ (2016) Anti-inflammatory effects of melatonin in multiple sclerosis. BioEssays 38:1016–1026. https://doi.org/10.1002/bies.201600018CrossRefPubMed

Fatima S, Zaidi SS, Alsharidah AS et al (2020) Possible prophylactic approach for SARS-CoV-2 infection by combination of melatonin, vitamin C and Zinc in animals. Front Vet Sci. https://doi.org/10.3389/fvets.2020.585789CrossRefPubMedPubMedCentral

Feng Y, Jia Y, Su L et al (2013) Decreased mitochondrial DNA copy number in the hippocampus and peripheral blood during opiate addiction is mediated by autophagy and can be salvaged by melatonin. Autophagy 9:1395–1406. https://doi.org/10.4161/AUTO.25468CrossRefPubMed

Feng YS, Tan ZX, Wu LY et al (2021) The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases. Biomed Pharmacother. https://doi.org/10.1016/j.biopha.2021.111428CrossRefPubMed

Fernández-Ortiz M, Sayed RKA, Fernández-Martínez J et al (2020) Melatonin/Nrf2/NLRP3 connection in mouse heart mitochondria during aging. Antioxidants 9:1–22. https://doi.org/10.3390/antiox9121187CrossRef

Fukutomi T, Takagi K, Mizushima T et al (2014) Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and keap1. Mol Cell Biol. https://doi.org/10.1128/mcb.01191-13CrossRefPubMedPubMedCentral

García JA, Volt H, Venegas C et al (2015) Disruption of the NF-κB/NLRP3 connection by melatonin requires retinoid-related orphan receptor-a and blocks the septic response in mice. FASEB J 29:3863–3875. https://doi.org/10.1096/fj.15-273656CrossRefPubMed

Ghareghani M, Dokoohaki S, Ghanbari A et al (2017a) Melatonin exacerbates acute experimental autoimmune encephalomyelitis by enhancing the serum levels of lactate: a potential biomarker of multiple sclerosis progression. Clin Exp Pharmacol Physiol 44:52–61. https://doi.org/10.1111/1440-1681.12678CrossRefPubMed

Ghareghani M, Sadeghi H, Zibara K et al (2017b) Melatonin increases oligodendrocyte differentiation in cultured neural stem cells. Cell Mol Neurobiol 37:1319–1324. https://doi.org/10.1007/S10571-016-0450-4CrossRefPubMed

Ghareghani M, Reiter RJ, Zibara K, Farhadi N (2018) Latitude, vitamin D, melatonin, and gut microbiota act in concert to initiate multiple sclerosis: a new mechanistic pathway. Front Immunol 9:2484. https://doi.org/10.3389/fimmu.2018.02484CrossRefPubMedPubMedCentral

Ghareghani M, Scavo L, Jand Y et al (2019) Melatonin therapy modulates cerebral metabolism and enhances remyelination by increasing PDK4 in a mouse model of multiple sclerosis. Front Pharmacol. https://doi.org/10.3389/fphar.2019.00147CrossRefPubMedPubMedCentral

Giannoulia-Karantana A, Vlachou A, Polychronopoulou S et al (2007) Melatonin and immunomodulation: connections and potential clinical applications. NeuroImmunoModulation 13:133–144. https://doi.org/10.1159/000097258CrossRef

Gioannini TL, Weiss JP (2007) Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells. Immunol Res 39:249–260. https://doi.org/10.1007/s12026-007-0069-0CrossRefPubMed

Golan D, Staun-Ram E, Glass-Marmor L et al (2013) The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis. Brain Behav Immun. https://doi.org/10.1016/j.bbi.2013.04.010CrossRefPubMed

Gold SM, Voskuhl RR (2009) Estrogen and testosterone therapies in multiple sclerosis. Prog Brain Res 175:239–251. https://doi.org/10.1016/S0079-6123(09)17516-7CrossRefPubMedPubMedCentral

Gold SM, Schulz KH, Hartmann S et al (2003) Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls. J Neuroimmunol 138:99–105. https://doi.org/10.1016/S0165-5728(03)00121-8CrossRefPubMed

Goldenberg MM (2012) Multiple sclerosis review. PT 37:175–184

Gonsette R (2008) Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? Mult Scler 14:22–34. https://doi.org/10.1177/1352458507080111CrossRefPubMed

Grumbach MM (2002) The neuroendocrinology of human puberty revisited. Horm Res Paediatr 57:2–14. https://doi.org/10.1159/000058094CrossRef

Gunata M, Parlakpinar H, Acet HA (2020) Melatonin: a review of its potential functions and effects on neurological diseases. Rev Neurol (paris) 176:148–165. https://doi.org/10.1016/j.neurol.2019.07.025CrossRef

Haider L (2015) Inflammation, iron, energy failure, and oxidative stress in the pathogenesis of multiple sclerosis. Oxid Med Cell Longev. https://doi.org/10.1155/2015/725370CrossRefPubMedPubMedCentral

Harbo HF, Gold R, Tintora M (2013) Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disord. https://doi.org/10.1177/1756285613488434CrossRefPubMedPubMedCentral

Hassanpour-Dehkordi A, Jivad N (2014) Comparison of regular aerobic and yoga on the quality of life in patients with multiple sclerosis. Med J Islam Repub Iran 28:141PubMedPubMedCentral

Hauser S, Goodwin D (2008) Multiple sclerosis and other demyelinating diseases. Harrison’s principles of internal medicine, 17th edn. McGraw-Hill Medical, New York, pp 2611–2621

Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med. https://doi.org/10.1084/jem.170.2.607CrossRefPubMed

Holick MF (1995) Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr. https://doi.org/10.1093/ajcn/61.3.638SCrossRefPubMed

Holton KF, Kirkland AE (2020) Moving past antioxidant supplementation for the dietary treatment of multiple sclerosis. Mult Scler J 26:1012–1023. https://doi.org/10.1177/1352458519893925CrossRef

HorlickK MB, Rosenbaum M, Nicholson M et al (2000) Effect of puberty on the relationship between circulating leptin and body composition. J Clin Endocrinol Metab 85:2509–2518. https://doi.org/10.1210/JCEM.85.7.6689CrossRef

Huang WJ, Chen WW, Zhang X (2017) Multiple sclerosis: pathology, diagnosis and treatments (review). Exp Ther Med 13:3163–3166. https://doi.org/10.3892/etm.2017.4410CrossRefPubMedPubMedCentral

Huang SH, Liao CL, Chen SJ et al (2019) Melatonin possesses an anti-influenza potential through its immune modulatory effect. J Funct Foods. https://doi.org/10.1016/j.jff.2019.04.062CrossRef

Huiberts LM, Smolders KCHJ (2021) Effects of vitamin D on mood and sleep in the healthy population: interpretations from the serotonergic pathway. Sleep Med Rev. https://doi.org/10.1016/j.smrv.2020.101379CrossRefPubMed

Iannucci A, Caneparo V, Raviola S et al (2020) Toll-like receptor 4-mediated inflammation triggered by extracellular IFI16 is enhanced by lipopolysaccharide binding. PLoS Pathog. https://doi.org/10.1371/JOURNAL.PPAT.1008811CrossRefPubMedPubMedCentral

Jehi L, Ji X, Milinovich A et al (2020) Individualizing risk prediction for positive coronavirus disease 2019 testing: results from 11,672 patients. Chest. https://doi.org/10.1016/j.chest.2020.05.580CrossRefPubMedPubMedCentral

Jin YP, De Pedro-Cuesta J, Söderström M et al (2000) Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis. J Neurol Sci 181:56–64. https://doi.org/10.1016/S0022-510X(00)00408-1CrossRefPubMed

Johnson DA, Amirahmadi S, Ward C et al (2009) The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicol Sci. https://doi.org/10.1093/toxsci/kfp274CrossRefPubMedPubMedCentral

Kahroba H, Ramezani B, Maadi H et al (2021) The role of Nrf2 in neural stem/progenitors cells: from maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease. Ageing Res Rev. https://doi.org/10.1016/j.arr.2020.101211CrossRefPubMed

Kamanli A, Naziroǧlu M, Aydilek N, Hacievliyagil C (2004) Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct. https://doi.org/10.1002/cbf.1055CrossRefPubMed

Kang JC, Ahn M, Kim YS et al (2001) Melatonin ameliorates autoimmune encephalomyelitis through suppression of intercellular adhesion molecule-1. J Vet Sci (Suwon-si, Korea). https://doi.org/10.4142/jvs.2001.2.2.85CrossRef

Kataria S, Tandon M, Melnic V, Sriwastava S (2020) A case series and literature review of multiple sclerosis and COVID-19: clinical characteristics, outcomes and a brief review of immunotherapies. eNeurologicalSci. https://doi.org/10.1016/j.ensci.2020.100287CrossRefPubMedPubMedCentral

Katsuoka F, Yamamoto M (2016) Small maf proteins (MafF, MafG, MafK): history, structure and function. Gene 586:197–205. https://doi.org/10.1016/j.gene.2016.03.058CrossRefPubMedPubMedCentral

Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol 11:373–384. https://doi.org/10.1038/ni.1863CrossRefPubMed

Kebir H, Kreymborg K, Ifergan I et al (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. https://doi.org/10.1038/nm1651CrossRefPubMedPubMedCentral

Kern S, Geiger M, Paucke M et al (2019) Clinical relevance of circadian melatonin release in relapsing-remitting multiple sclerosis. J Mol Med 97:1547–1555. https://doi.org/10.1007/s00109-019-01821-wCrossRefPubMed

Kim SW, Kim S, Son M et al (2020) Melatonin controls microbiota in colitis by goblet cell differentiation and antimicrobial peptide production through Toll-like receptor 4 signalling. Sci Rep. https://doi.org/10.1038/s41598-020-59314-7CrossRefPubMedPubMedCentral

Knaepen K, Goekint M, Heyman EM, Meeusen R (2010) Neuroplasticity exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects. Sport Med 40:765–801. https://doi.org/10.2165/11534530-000000000-00000CrossRef

Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM (2008) IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med. https://doi.org/10.1084/jem.20080159CrossRefPubMedPubMedCentral

Kubo E, Chhunchha B, Singh P et al (2017) Sulforaphane reactivates cellular antioxidant defense by inducing Nrf2/ARE/Prdx6 activity during aging and oxidative stress. Sci Rep 7:1–17. https://doi.org/10.1038/s41598-017-14520-8CrossRef

Lahooti B, Chhibber T, Bagchi S et al (2021) Therapeutic role of inflammasome inhibitors in neurodegenerative disorders. Brain Behav Immun 91:771–783. https://doi.org/10.1016/j.bbi.2020.11.004CrossRefPubMed

Langhnoja J, Buch L, Pillai P (2021) Potential role of NGF, BDNF, and their receptors in oligodendrocytes differentiation from neural stem cell: an in vitro study. Cell Biol Int 45:432–446. https://doi.org/10.1002/cbin.11500CrossRefPubMed

Lassmann H, van Horssen J (2016) Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions. Biochim Biophys Acta - Mol Basis Dis. https://doi.org/10.1016/j.bbadis.2015.09.018CrossRef

Lassmann H, Brück W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17:210–218. https://doi.org/10.1111/j.1750-3639.2007.00064.xCrossRefPubMedPubMedCentral

Lassmann H, van Horssen J, Mahad D (2012) Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol 8:647–656. https://doi.org/10.1038/NRNEUROL.2012.168CrossRefPubMed

Leon J, Acuña-Castroviejo D, Sainz R et al (2004) Melatonin and mitochondrial function. Life Sci 75:765–790. https://doi.org/10.1016/J.LFS.2004.03.003CrossRefPubMed

Li DY, Smith DG, Hardel R et al (2013) Melatonin receptor genes in vertebrates. Int J Mol Sci 14:11208–11223. https://doi.org/10.3390/ijms140611208CrossRefPubMedPubMedCentral

Licht-Mayer S, Wimmer I, Traffehn S et al (2015) Cell type-specific Nrf2 expression in multiple sclerosis lesions. Acta Neuropathol 130:263–277. https://doi.org/10.1007/s00401-015-1452-xCrossRefPubMedPubMedCentral

Liebenthron J, Reinsberg J, Van Der Ven K et al (2019) Serum anti-müllerian hormone concentration and follicle density throughout reproductive life and in different diseases - implications in fertility preservation. Hum Reprod 34:2513–2522. https://doi.org/10.1093/humrep/dez215CrossRefPubMed

Lin GJ, Huang SH, Chen SJ et al (2013) Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases. Int J Mol Sci 14:11742–11766. https://doi.org/10.3390/ijms140611742CrossRefPubMedPubMedCentral

Lock C, Hermans G, Pedotti R et al (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. https://doi.org/10.1038/nm0502-500CrossRefPubMed

Loffreda S, Yang SQ, Lin HZ et al (1998) Leptin regulates proinflammatory immune responses. FASEB J 12:57–65. https://doi.org/10.1096/FSB2FASEBJ.12.1.57CrossRefPubMed

Long T, Yang Y, Peng L, Li Z (2018) Neuroprotective effects of melatonin on experimental allergic encephalomyelitis mice via anti-oxidative stress activity. J Mol Neurosci 64:233–241. https://doi.org/10.1007/s12031-017-1022-xCrossRefPubMed

Lopes J, Arnosti D, Trosko JE et al (2016) Melatonin decreases estrogen receptor binding to estrogen response elements sites on the oct4 gene in human breast cancer stem cells. Genes and Cancer 7:209–217. https://doi.org/10.18632/genesandcancer.107CrossRefPubMedPubMedCentral

Luna G, Alping P, Burman J et al (2020) Infection risks among patients with multiple sclerosis treated with fingolimod, natalizumab, rituximab, and injectable therapies. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2019.3365CrossRefPubMed

Luo J, Zhang Z, Sun H et al (2020) Effect of melatonin on T/B cell activation and immune regulation in pinealectomy mice. Life Sci. https://doi.org/10.1016/j.lfs.2019.117191CrossRefPubMed

Maes M, Landucci Bonifacio K, Morelli NR et al (2019) Major differences in neurooxidative and neuronitrosative stress pathways between major depressive disorder and types I and II bipolar disorder. Mol Neurobiol 56:141–156. https://doi.org/10.1007/S12035-018-1051-7/TABLES/5CrossRefPubMed

Mahad DH, Trapp BD, Lassmann H (2015) Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol 14:183–193. https://doi.org/10.1016/S1474-4422(14)70256-XCrossRefPubMed

Maldonado MD, Mora-Santos M, Naji L et al (2010) Evidence of melatonin synthesis and release by mast cells. Possible modulatory role on inflammation. Pharmacol Res 62:282–287. https://doi.org/10.1016/j.phrs.2009.11.014CrossRefPubMed

Marcus JM, Andrabi SA (2018) SIRT3 Regulation under cellular stress: making sense of the ups and downs. Front Neurosci 12:799. https://doi.org/10.3389/fnins.2018.00799CrossRefPubMedPubMedCentral

Martín M, Macías M, Escames G et al (2000a) Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB J 14:1677–1679. https://doi.org/10.1096/FJ.99-0865FJECrossRefPubMed

Martín M, Macías M, Escames G et al (2000b) Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J Pineal Res 28:242–248. https://doi.org/10.1034/J.1600-079X.2000.280407.XCrossRefPubMed

Martín M, Macías M, León J et al (2002) Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int J Biochem Cell Biol 34:348–357. https://doi.org/10.1016/S1357-2725(01)00138-8CrossRefPubMed

Martín Giménez VM, Inserra F, Tajer CD et al (2020) Lungs as target of COVID-19 infection: protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. Life Sci. https://doi.org/10.1016/j.lfs.2020.117808CrossRefPubMedPubMedCentral

Martinez B, Peplow PV (2020) Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014–2019. Neural Regen Res 15:1220–1234. https://doi.org/10.4103/1673-5374.272572CrossRefPubMedPubMedCentral

Matías-Guiu J, Gomez-Pinedo U, Montero-Escribano P et al (2020) Should we expect neurological symptoms in the SARS-CoV-2 epidemic? Neurologia 35:170–175. https://doi.org/10.1016/j.nrl.2020.03.001CrossRefPubMedPubMedCentral

Medina FJ, Túnez I (2013) Mechanisms and pathways underlying the therapeutic effect of transcranial magnetic stimulation. Rev Neurosci 24:507–525. https://doi.org/10.1515/revneuro-2013-0024CrossRefPubMed

Medina-Fernandez F, Escribano B, Agüera E et al (2017) Effects of transcranial magnetic stimulation on oxidative stress in experimental autoimmune encephalomyelitis. Free Radic Res 51:460–469. https://doi.org/10.1080/10715762.2017.1324955CrossRefPubMed

Medina-Fernandez F, Escribano B, Luque E et al (2018) Comparative of transcranial magnetic stimulation and other treatments in experimental autoimmune encephalomyelitis. Brain Res Bull 137:140–145. https://doi.org/10.1016/J.BRAINRESBULL.2017.11.018CrossRefPubMed

Medina-Fernández FJ, Luque E, Aguilar-Luque M et al (2017) Transcranial magnetic stimulation modifies astrocytosis, cell density and lipopolysaccharide levels in experimental autoimmune encephalomyelitis. Life Sci. https://doi.org/10.1016/j.lfs.2016.11.011CrossRefPubMed

Medina-Fernández F, Escribano B, Padilla-Del-Campo C et al (2018) Transcranial magnetic stimulation as an antioxidant. Free Radic Res 52:381–389. https://doi.org/10.1080/10715762.2018.1434313CrossRefPubMed

Melatonin in Patients With Multiple Sclerosis (MS). - Full Text View - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT3498131/. Accessed 3 Sep 2021

Mendiola AS, Cardona AE (2018) The IL-1β phenomena in neuroinflammatory diseases. J Neural Transm 125:781–795. https://doi.org/10.1007/s00702-017-1732-9CrossRefPubMed

Merad M, Martin JC (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 20:355–362. https://doi.org/10.1038/s41577-020-0331-4CrossRefPubMedPubMedCentral

Michaličková D, Hrnčíř T, Canová NK, Slanař O (2020a) Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis. Eur J Pharmacol. https://doi.org/10.1016/j.ejphar.2020.172973CrossRefPubMed

Michaličková D, Šíma M, Slanař O (2020) New insights in the mechanisms of impaired redox signaling and its interplay with inflammation and immunity in multiple sclerosis. Physiol Res 69:1–19. https://doi.org/10.33549/physiolres.934276CrossRefPubMed

Miller E, Mrowicka M, Malinowska K et al (2011) Effects of whole-body cryotherapy on a total antioxidative status and activities of antioxidative enzymes in blood of depressive multiple sclerosis patients. World J Biol Psychiatry 12:223–227. https://doi.org/10.3109/15622975.2010.518626CrossRefPubMed

Miller E, Walczak A, Majsterek I, Kędziora J (2013) Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course. J Neuroimmunol 257:97–101. https://doi.org/10.1016/J.JNEUROIM.2013.02.012CrossRefPubMed

Miyake S, Kim S, Suda W et al (2015) Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS ONE. https://doi.org/10.1371/journal.pone.0137429CrossRefPubMedPubMedCentral

Mocayar-Marón FJ, Ferder L, Reiter RJ, Manucha W (2020) Daily and seasonal mitochondrial protection: unraveling common possible mechanisms involving vitamin D and melatonin. J Steroid Biochem Mol Biol. https://doi.org/10.1016/j.jsbmb.2020.105595CrossRefPubMed

Morris G, Walker AJ, Walder K et al (2021) Increasing Nrf2 activity as a treatment approach in neuropsychiatry. Mol Neurobiol 58:2158–2182. https://doi.org/10.1007/s12035-020-02212-wCrossRefPubMed

Musshoff U, Riewenherm D, Berger E et al (2002) Melatonin receptors in rat hippocampus: molecular and functional investigations. Hippocampus. https://doi.org/10.1002/hipo.1105CrossRefPubMed

Naegelin Y, Saeuberli K, Schaedelin S et al (2020) Levels of brain-derived neurotrophic factor in patients with multiple sclerosis. Ann Clin Transl Neurol 7:2251–2261. https://doi.org/10.1002/acn3.51215CrossRefPubMedPubMedCentral

Nien HC, Hsu SJ, Su TH et al (2017) High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments. PLoS ONE. https://doi.org/10.1371/journal.pone.0170028CrossRefPubMedPubMedCentral

Niles LP, Armstrong KJ, Rincón Castro LM et al (2004) Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers. BMC Neurosci. https://doi.org/10.1186/1471.2202-5-41CrossRefPubMedPubMedCentral

Noto D, Miyake S (2020) Gut dysbiosis and multiple sclerosis. Clin Immunol. https://doi.org/10.1016/j.clim.2020.108380CrossRefPubMed

Ochoa-Repáraz J, Mielcarz DW, Begum- Haque S, Kasper LH (2011) Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann Neurol. https://doi.org/10.1002/ana.22344CrossRefPubMed

Ogłodek EA, Just MJ, Szromek AR, Araszkiewicz A (2016) Melatonin and neurotrophins NT-3, BDNF, NGF in patients with varying levels of depression severity. Pharmacol Reports 68:945–951. https://doi.org/10.1016/j.pharep.2016.04.003CrossRef

Onaolapo OJ, Onaolapo AY, Olowe OA et al (2019) Melatonin and melatonergic influence on neuronal transcription factors: implications for the development of novel therapies for neurodegenerative disorders. Curr Neuropharmacol 18:563–577. https://doi.org/10.2174/1570159x18666191230114339CrossRef

Ontaneda D, Hyland M, Cohen JA (2012) Multiple sclerosis: new insights in pathogenesis and novel therapeutics. Annu Rev Med 63:389–404. https://doi.org/10.1146/annurev-med-042910-135833CrossRefPubMed

Oraby MI, El Masry HA, Abd El Shafy SS, Abdul Galil EM (2021) Serum level of brain-derived neurotrophic factor in patients with relapsing–remitting multiple sclerosis: a potential biomarker for disease activity. Egypt J Neurol Psychiatry Neurosurg. https://doi.org/10.1186/s41983-021-00296-2CrossRef

Padureanu R, Albu CV, Mititelu RR et al (2019) Oxidative stress and inflammation interdependence in multiple sclerosis. J Clin Med 8:1815. https://doi.org/10.3390/JCM8111815CrossRefPubMedCentral

Palao M, Fernández-Díaz E, Gracia-Gil J et al (2020) Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord. https://doi.org/10.1016/j.msard.2020.102377CrossRefPubMedPubMedCentral

Palmer ACS, Zortea M, Souza A et al (2020) Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: a randomized, double-blind, placebo-controlled trial. PLoS ONE. https://doi.org/10.1371/journal.pone.0231379CrossRefPubMedPubMedCentral

Pandit A, Vadnal J, Houston S et al (2009) Impaired regulation of electron transport chain subunit genes by nuclear respiratory factor 2 in multiple sclerosis. J Neurol Sci. https://doi.org/10.1016/j.jns.2009.01.009CrossRefPubMed

Paradies G, Petrosillo G, Paradies V et al (2010) Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 48:297–310. https://doi.org/10.1111/j.1600-079X.2010.00759.xCrossRefPubMed

Park JS, Piao J, Park G, Hong HS (2020) Substance-P restores cellular activity of adsc impaired by oxidative stress. Antioxidants 9:1–10. https://doi.org/10.3390/ANTIOX9100978CrossRef

Patsopoulos NA, Barcellos LF, Hintzen RQ et al (2013) Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and Non-HLA effects. PLoS Genet. https://doi.org/10.1371/journal.pgen.1003926CrossRefPubMedPubMedCentral

Pegoretti V, Swanson KA, Bethea JR et al (2020) Inflammation and oxidative stress in multiple sclerosis: consequences for therapy development. Oxid Med Cell Longev. https://doi.org/10.1155/2020/7191080CrossRefPubMedPubMedCentral

Pozzilli C, De Giglio L, Barletta VT et al (2015) Oral contraceptives combined with interferon b in multiple sclerosis. Neurol Neuroimmunol NeuroInflammation. https://doi.org/10.1212/NXI.0000000000000120CrossRef

Proietti S, Cucina A, D’Anselmi F et al (2011) Melatonin and vitamin D 3 synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells. J Pineal Res 50:150–158. https://doi.org/10.1111/j.1600-079X.2010.00824.xCrossRefPubMed

Ramagopalan SV, Dyment DA, Cader MZ et al (2011) Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann Neurol 70:881–886. https://doi.org/10.1002/ana.22678CrossRefPubMed

Ramirez-Ramirez V, Macias-Islas MA, Ortiz GG et al (2013) Efficacy of fish oil on serum of TNF α, IL-1 β, and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b. Oxid Med Cell Longev. https://doi.org/10.1155/2013/709493CrossRefPubMedPubMedCentral

Ramos González EJ, Ramirez Jirano LJ, García Martínez DZ et al (2018) Estudio comparativo de melatonina contra los tratamientos inmunomoduladores (interferón beta y acetato de glatirámero) en un modelo murino de esclerosis múltiple. Neurologia. https://doi.org/10.1016/j.nrl.2018.01.007CrossRefPubMed

Rateb EE, Amin SN, El-Tablawy N et al (2017) Effect of melatonin supplemented at the light or dark period on recovery of sciatic nerve injury in rats. EXCLI J 16:138–150. https://doi.org/10.1779/excli2016-763CrossRefPubMedPubMedCentral

Reiter R, Calvo J, Karbownik M et al (2000) Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 917:376–386. https://doi.org/10.1111/J.1749-6632.2000.TB05402.XCrossRefPubMed

Reiter RJ, Tan DX, Rosales-Corral S et al (2018) Melatonin mitigates mitochondrial meltdown: Interactions with SIRT3. Int J Mol Sci. https://doi.org/10.3390/ijms19082439CrossRefPubMedPubMedCentral

Ribbons KA, McElduff P, Boz C et al (2015) Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS. PLoS ONE. https://doi.org/10.1371/journal.pone.0122686CrossRefPubMedPubMedCentral

Romero A, Ramos E, López-Muñoz F et al (2020) Coronavirus disease 2019 (COVID-19) and Its neuroinvasive capacity: is it time for melatonin? Cell Mol Neurobiol 42:489–500. https://doi.org/10.1007/s10571-020-00938-8CrossRefPubMedPubMedCentral

Roostaei T, Sahraian MA, Hajeaghaee S et al (2015) Impact of melatonin on motor, cognitive and neuroimaging indices in patients with multiple sclerosis. Iran J Allergy, Asthma Immunol 14(6):589–95

Roostaei T, Klein H-U, Ma Y et al (2021) Proximal and distal effects of genetic susceptibility to multiple sclerosis on the T cell epigenome. Nat Commun. https://doi.org/10.1038/S41467-021-27427-WCrossRefPubMedPubMedCentral

Rosales-Corral S, Acuña-Castroviejo D, Coto-Montes A et al (2012) Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin. J Pineal Res 52:167–202. https://doi.org/10.1111/J.1600-079X.2011.00937.XCrossRefPubMed

Ryu JK, Kim SJ, Rah SH et al (2017) Reconstruction of LPS transfer cascade reveals structural determinants within LBP, CD14, and TLR4-MD2 for efficient LPS recognition and transfer. Immunity 46:38–50. https://doi.org/10.1016/j.immuni.2016.11.007CrossRefPubMed

Sakkas GK, Giannaki CD, Karatzaferi C, Manconi M (2019) Sleep abnormalities in multiple sclerosis. Curr Treat Options Neurol 21:4. https://doi.org/10.1007/s11940-019-0544-7CrossRefPubMed

Sánchez-López AL, Ortiz GG, Pacheco-Moises FP et al (2018) Efficacy of melatonin on serum pro-inflammatory cytokines and oxidative stress markers in relapsing remitting multiple sclerosis. Arch Med Res 49:391–398. https://doi.org/10.1016/j.arcmed.2018.12.004CrossRefPubMed

Sandri G, Panfili E, Ernster L (1990) Hydrogen peroxide production by monoamine oxidase in isolated rat-brain mitochondria: its effect on glutathione levels and Ca2+ efflux. Biochim Biophys Acta 1035:300–305. https://doi.org/10.1016/0304-4165(90)90092-BCrossRefPubMed

Sarchielli P, Zaffaroni M, Floridi A et al (2007) Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-β 1a, and high doses of immunoglobulins. Mult Scler 13:313–331. https://doi.org/10.1177/1352458506070146CrossRefPubMed

Senthil Kumaran V, Arulmathi K, Srividhya R, Kalaiselvi P (2008) Repletion of antioxidant status by EGCG and retardation of oxidative damage induced macromolecular anomalies in aged rats. Exp Gerontol 43:176–183. https://doi.org/10.1016/J.EXGER.2007.10.017CrossRefPubMed

Sepúlveda M, Ros C, Martínez-Lapiscina EH et al (2016) Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: a pilot study. Mult Scler 22:564–568. https://doi.org/10.1177/1352458515602339CrossRefPubMed

Sezgin G, Öztürk G, Güney Ş et al (2013) Protective effect of melatonin and 1,25-dihydroxyvitamin d3 on renal ischemia-reperfusion injury in rats. Ren Fail 35:374–379. https://doi.org/10.3109/0886022X.2012.760409CrossRefPubMed

Shah SA, Khan M, Jo MH et al (2017) Melatonin stimulates the SIRT1/Nrf2 signaling pathway counteracting lipopolysaccharide (LPS)-induced oxidative stress to rescue postnatal rat brain. CNS Neurosci Ther 23:33–44. https://doi.org/10.1111/cns.12588CrossRefPubMed

Sharief MK, Hentges R (1991) Association between tumor Necrosis factor-α and disease progression in patients with multiple sclerosis. N Engl J Med. https://doi.org/10.1056/nejm199108153250704CrossRefPubMed

Shih PH (2006) Yen GC (2006) differential expressions of antioxidant status in aging rats: the role of transcriptional factor Nrf2 and MAPK signaling pathway. Biogerontology 82(8):71–80. https://doi.org/10.1007/S10522-006-9033-YCrossRef

Sicotte NL, Giesser BS, Tandon V et al (2007) Testosterone treatment in multiple sclerosis: a pilot study. Arch Neurol 64:683–688. https://doi.org/10.1001/archneur.64.5.683CrossRefPubMed

Silvagno F, Pescarmona G (2017) Spotlight on vitamin D receptor, lipid metabolism and mitochondria: some preliminary emerging issues. Mol Cell Endocrinol 450:24–31. https://doi.org/10.1016/j.mce.2017.04.013CrossRefPubMed

Simon KC, Munger KL, Ascherio A (2012) Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics. Curr Opin Neurol 25:246–251. https://doi.org/10.1097/WCO.0b013e3283533a7eCrossRefPubMedPubMedCentral

Şimşek Ş, Gençoǧlan S, Yüksel T et al (2016) Oxidative stress and DNA damage in untreated first-episode psychosis in adolescents. Neuropsychobiology 73:92–97. https://doi.org/10.1159/000444488CrossRefPubMed

Siotto M, Filippi MM, Simonelli I et al (2019) Oxidative stress related to iron metabolism in relapsing remitting multiple sclerosis patients with low disability. Front Neurosci. https://doi.org/10.3389/fnins.2019.00086CrossRefPubMedPubMedCentral

Skarlis C, Anagnostouli M (2020) The role of melatonin in multiple sclerosis. Neurol Sci 41:769–781CrossRef

Soares JL, Oliveira EM, Pontillo A (2019) Variants in NLRP3 and NLRC4 inflammasome associate with susceptibility and severity of multiple sclerosis. Mult Scler Relat Disord 29:26–34. https://doi.org/10.1016/j.msard.2019.01.023CrossRefPubMed

Song C, Zhao J, Fu B et al (2017) Melatonin-mediated upregulation of Sirt3 attenuates sodium fluoride-induced hepatotoxicity by activating the MT1-PI3K/AKT-PGC-1α signaling pathway. Free Radic Biol Med 112:616–630. https://doi.org/10.1016/J.FREERADBIOMED.2017.09.005CrossRefPubMed

Soto-Brambila AP, Gabriel Ortiz G, Rivero-Moragrega P et al (2017) Relapsing remitting multiple sclerosis and its relationship with the immune system and oxidative stress. Curr Immunol Rev 14:15–23. https://doi.org/10.2174/1573395514666171226154300CrossRef

Spelman T, Gray O, Trojano M et al (2014) Seasonal variation of relapse rate in multiple sclerosis is latitude dependent. Ann Neurol 76:880–890. https://doi.org/10.1002/ANA.24287CrossRefPubMed

Stadelmann C, Kerschensteiner M, Misgeld T et al (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 125:75–85. https://doi.org/10.1093/brain/awf015CrossRefPubMed

Straub RH (2007) The complex role of estrogens in inflammation. Endocr Rev 28:521–574. https://doi.org/10.1210/er.2007-0001CrossRefPubMed

Sugiyama A, Kato H, Takakura H et al (2020) Effects of physical activity and melatonin on brain-derived neurotrophic factor and cytokine expression in the cerebellum of high-fat diet-fed rats. Neuropsychopharmacol Reports 40:291–296. https://doi.org/10.1002/npr2.12125CrossRef

Tan DX, Hardeland R (2020) Targeting host defense system and rescuing compromised mitochondria to increase tolerance against pathogens by melatonin may impact outcome of deadly virus infection pertinent to COVID-19. Molecules 25:4410. https://doi.org/10.3390/molecules25194410CrossRefPubMedCentral

Tan DX, Xu B, Zhou X, Reiter RJ (2018) Pineal calcification, melatonin production, aging, associated health consequences and rejuvenation of the pineal gland. Mol A J Synth Chem Nat Prod Chem. https://doi.org/10.3390/MOLECULES23020301CrossRef

Tasset I, Drucker-Colín R, Peña J et al (2010) Antioxidant-like effects and protective action of transcranial magnetic stimulation in depression caused by olfactory bulbectomy. Neurochem Res. https://doi.org/10.1007/s11064-010-0172-9CrossRefPubMed

Tasset I, Agüera E, Olmo-Camacho R et al (2011) Melatonin improves 3-nitropropionic acid induced behavioral alterations and neurotrophic factors levels. Prog Neuro-Psychopharmacology Biol Psychiatry 35:1944–1949. https://doi.org/10.1016/j.pnpbp.2011.09.005CrossRef

Tasset I, Agüera E, Sánchez-López F et al (2012) Peripheral oxidative stress in relapsing-remitting multiple sclerosis. Clin Biochem 45:440–444. https://doi.org/10.1016/J.CLINBIOCHEM.2012.01.023CrossRefPubMed

Thöne J, Kollar S, Nousome D et al (2015) Serum anti-Müllerian hormone levels in reproductive-age women with relapsing-remitting multiple sclerosis. Mult Scler J 21:41–47. https://doi.org/10.1177/1352458514540843CrossRef

Torrens-Mas M, Roca P, Sastre-Serra J, Margalida Torrens-Mas C (2017) Importancia de la sirtuina 3 en el estrés oxidativo y el cáncer Role of sirtuin 3 in oxidative stress and cancer. Med Balear 32:47–52. https://doi.org/10.3306/MEDICINABALEAR.32.02.47CrossRef

Trachootham D, Lu W, Ogasawara MA et al (2008) Redox regulation of cell survival. Antioxid Redox Signal 10:1343. https://doi.org/10.1089/ARS.2007.1957CrossRefPubMedPubMedCentral

Túnez I, Montilla P, Muñoz MDC et al (2004) Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington’s disease. J Pineal Res 37:252–256. https://doi.org/10.1111/j.1600-079X.2004.00163.xCrossRefPubMed

Valacchi G, Virgili F, Cervellati C, Pecorelli A (2018) OxInflammation: from subclinical condition to pathological biomarker. Front Physiol 9:858. https://doi.org/10.3389/fphys.2018.00858CrossRefPubMedPubMedCentral

van den Hoogen WJ, Laman JD, Hart T, BA, (2017) Modulation of multiple sclerosis and its animal model experimental autoimmune encephalomyelitis by food and gut microbiota. Front Immunol. https://doi.org/10.3389/fimmu.2017.01081CrossRefPubMedPubMedCentral

Villanueva R (2013) Neurobiology of major depressive disorder. Neural Plast. https://doi.org/10.1155/2013/873278CrossRefPubMedPubMedCentral

Walshe JM (2005) Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease. Mov Disord. https://doi.org/10.1002/mds.20628CrossRefPubMed

Wang X (2009) The antiapoptotic activity of melatonin in neurodegenerative diseases. CNS Neurosci Ther 15:345. https://doi.org/10.1111/j.1755-5949.2009.00105.xCrossRefPubMedPubMedCentral

Wang Y, Liu X, Wang W et al (2013) The expression of inflammatory cytokines on the aorta endothelia are up-regulated in pinealectomized rats. Inflammation 36:1363–1373. https://doi.org/10.1007/S10753-013-9676-1CrossRefPubMed

Wang Y, Han D, Zhou T et al (2020) Melatonin ameliorates aortic valve calcification via the regulation of circular RNA CircRIC3/miR-204-5p/DPP4 signaling in valvular interstitial cells. J Pineal Res. https://doi.org/10.1111/jpi.12666CrossRefPubMedPubMedCentral

Waubant E (2018) Effect of puberty on multiple sclerosis risk and course. Mult Scler 24:32–35. https://doi.org/10.1177/1352458517737393CrossRefPubMed

Wekerle H, Berer K, Krishnamoorthy G (2013) Remote control-triggering of brain autoimmune disease in the gut. Curr Opin Immunol 25:683–689. https://doi.org/10.1016/j.coi.2013.09.009CrossRefPubMed

Wijnands JMA, Zhu F, Kingwell E et al (2018) Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2017-317493CrossRefPubMed

Willis MD, Robertson NP (2020) Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2. J Neurol. https://doi.org/10.1007/s00415-020-09822-3CrossRefPubMedPubMedCentral

Wongchitrat P, Shukla M, Sharma R et al (2021) Role of melatonin on virus-induced neuropathogenesis—a concomitant therapeutic strategy to understand SARS-CoV-2 infection. Antioxidants 10:1–31. https://doi.org/10.3390/antiox10010047CrossRef

Woo MMM, Tai CJ, Kang SK et al (2001) Direct action of melatonin in human granulosa-luteal cells. J Clin Endocrinol Metab 86:4789–4797. https://doi.org/10.1210/jcem.86.10.7912CrossRefPubMed

Wu HHM, Xie QQM, Zhao CCC et al (2019) Melatonin biosynthesis restored by CpG oligodeoxynucleotides attenuates allergic airway inflammation via regulating NLRP3 inflammasome. Life Sci. https://doi.org/10.1016/j.lfs.2019.117067CrossRefPubMedPubMedCentral

Xu X, Wang G, Ai L et al (2018) Melatonin suppresses TLR9-triggered proinflammatory cytokine production in macrophages by inhibiting ERK1/2 and AKT activation. Sci Rep. https://doi.org/10.1038/s41598-018-34011-8CrossRefPubMedPubMedCentral

Yeganeh-Salehpour M, Mollica A, Momtaz S et al (2019) Melatonin and multiple sclerosis: from plausible neuropharmacological mechanisms of action to experimental and clinical evidence. Clin Drug Investig 39:607–624. https://doi.org/10.1007/s40261-019-00793-6CrossRefPubMed

Yi S, Yang Y (2021) Melatonin attenuates low shear stress-induced pyroptosis and endothelial cell dysfunction via the RORα/miR-223/STAT-3 signalling pathway. Exp Ther Med. https://doi.org/10.3892/ETM.2021.10828CrossRefPubMedPubMedCentral

Yosefifard M, Vaezi G, Malekirad AA et al (2019) A randomized control trial study to determine the effect of melatonin on serum levels of IL-1β and TNF-α in patients with multiple sclerosis. Iran J Allergy, Asthma Immunol 18:649–654. https://doi.org/10.18502/ijaai.v18i6.2177CrossRef

Yosefi-Fard M, Vaezi G, Maleki-Rad AA et al (2020) Effect of melatonin on serum levels of inf-1ß and vitamin b12 in patients with multiple sclerosis: a randomized controlled trial. Iran J Toxicol 14:19–24. https://doi.org/10.32598/ijt.14.1.19CrossRef

Yu X, Rollins D, Ruhn KA et al (2013) TH17 cell differentiation is regulated by the circadian clock. Science (80-). https://doi.org/10.1126/science.1243884CrossRefPubMedPubMedCentral

Yu GM, Kubota H, Okita M, Maeda T (2017) The anti-inflammatory and antioxidant effects of melatonin on LPS-stimulated bovine mammary epithelial cells. PLoS ONE. https://doi.org/10.1371/journal.pone.0178525CrossRefPubMedPubMedCentral

Yue Y, Stone S, Lin W (2018) Role of nuclear factor κb in multiple sclerosis and experimental autoimmune encephalomyelitis. Neural Regen Res 13:1507–1515. https://doi.org/10.4103/1673-5374.237109CrossRefPubMedPubMedCentral

Zeydan B, Atkinson EJ, Weis DM et al (2020) Reproductive history and progressive multiple sclerosis risk in women. Brain Commun. https://doi.org/10.1093/braincomms/fcaa185CrossRefPubMedPubMedCentral

Zhang L, Zhang H, Liang X et al (2013) Melatonin ameliorates cognitive impairment induced by sleep deprivation in rats: role of oxidative stress, BDNF and CaMKII. Behav Brain Res 256:72–81. https://doi.org/10.1016/J.BBR.2013.07.051CrossRefPubMed

Zhang R, Wang X, Ni L et al (2020) COVID-19: melatonin as a potential adjuvant treatment. Life Sci 250:117583. https://doi.org/10.1016/j.lfs.2020.117583CrossRefPubMedPubMedCentral

Zhao C, Wang P, Mao YM et al (2019) Potential role of melatonin in autoimmune diseases. Cytokine Growth Factor Rev 48:1–10. https://doi.org/10.1016/j.cytogfr.2019.07.002CrossRefPubMed

Zhou W, Liu Y, Shen J et al (2019) Melatonin increases bone mass around the prostheses of OVX rats by ameliorating mitochondrial oxidative stress via the SIRT3/SOD2 signaling pathway. Oxid Med Cell Longev. https://doi.org/10.1155/2019/4019619CrossRefPubMedPubMedCentral

Zhou Y, Hou Y, Shen J et al (2020) A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19. PLoS Biol. https://doi.org/10.1371/journal.pbio.3000970CrossRefPubMedPubMedCentral

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action

Abstract

Background

Aim

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Aim

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2022

Syringol isolated from Eleusine coracana (L.) Gaertn bran suppresses inflammatory response through the down-regulation of cPLA2, COX-2, IκBα, p38 and MPO signaling in sPLA2 induced mice paw oedema

Role of the NRG1/ErbB4 and PI3K/AKT/mTOR signaling pathways in the anti-psychotic effects of aripiprazole and sertindole in ketamine-induced schizophrenia-like behaviors in rats

Novel anti-arthritic mechanisms of trans-cinnamaldehyde against complete Freund’s adjuvant-induced arthritis in mice: involvement of NF-кB/TNF-α and IL-6/IL-23/ IL-17 pathways in the immuno-inflammatory responses

Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling

Therapeutic effect of the sulforaphane derivative JY4 on ulcerative colitis through the NF-κB-p65 pathway

Retraction Note to: Phytofabricated silver nanoparticles of Phyllanthus emblica attenuated diethylnitrosamine‑induced hepatic cancer via knock‑down oxidative stress and inflammation